Monkeypox Vaccine Equity Pilot Program

 

Vials of monkeypox vaccine provided at no cost for projects seeking to address vaccination disparities among one or more priority population groups most affected by monkeypox.

Sponsor
Centers for Disease Control and Prevention
 
Deadlines
Applications accepted on an ongoing basis
 
Contact

Use the contact form at the bottom of the program website.

 

Purpose

The Centers for Disease Control and Prevention will provide vials of monkeypox vaccine provided at no cost for projects seeking to address vaccination disparities among one or more priority population groups most affected by monkeypox.

Projects should make dedicated efforts to reach populations who face barriers to awareness, education, and prevention measures like vaccination. Barriers could include differences in language, location of vaccination sites, vaccine hesitancy, mistrust of government, and lack of access to online scheduling technology. Additionally, affected individuals may avoid accessing vaccination at events oriented toward specific sexual or gender identities or sexual activity out of fear of being stigmatized.

Project examples include:

  • Pop-ups and other events associated with community-based organizations (CBOs) or clinics that work with MSM and transgender and gender-diverse people who have sex with men, especially those who are Black/African American and Hispanic/Latino, who are not reached by current allocations or vaccine administration channels
  • Small events reaching priority populations
  • Other activities in settings where monkeypox is known to be spreading
  • Vaccine clinics at pharmacies, especially independent pharmacies in rural areas or areas with demonstrated vaccination disparities based on Social Vulnerability Index or other local data
Eligibility

Eligible applicants include:

  • State or territorial health departments
  • Tribal governments or federally funded tribal healthcare facilities (including Indian Health Services-operated facilities, tribal health programs, and Urban Indian Organizations)
  • Cities currently receiving monkeypox vaccines through the Strategic National Stockpile (SNS)
Geographic coverage
Nationwide
 
Amount of funding

10,000 vials of vaccine (enough for up to 50,000 intradermal doses) have been set aside for the pilot program. CDC recommends requesting up to 100 vials (300–500 doses) up front per project.

Application process

All proposals must be submitted through state or territorial health departments, tribal governments, federally funded tribal healthcare facilities, or cities currently receiving monkeypox vaccines through the SNS. Organizations interested in applying should reach out to their submitting jurisdiction.

Use the contact form at the bottom of the program website to request information on the submitting jurisdiction.

 

Facebook
Twitter
Email